Author Archives: Charles Moore

Young People with Alport Syndrome Can Apply for Life-enriching Paul Silver Tribute Award

The Alport Syndrome Foundation is inviting young people with the disease to apply for an award that allows them to pursue an activity or complete a project. November 3 is the deadline for applying for the 2018 Paul Silver Tribute Award, which is aimed at enriching the lives of Alport patients…

Setback in Regulus Candidate for Alport Syndrome Treatment Expected to Be Temporary

Regulus is leveraging its oligonucleotide drug discovery and expertise to develop innovative medicines that target microRNAs for the treatment of several diseases, including Alport syndrome. MicroRNAs are small non-coding RNA molecules that regulate most genes in plants, animals, and some viruses. According to Regulus, a single microRNA can target and regulate hundreds…